US-based pharmaceutical giant Moderna is studying two booster shot options designed to anticipate mutations similar to the Omicron strain of the coronavirus, which has been designated as a variant of concern by the WHO.
It is already working to test the ability of the current vaccine dose to neutralise the Omicron variant and data is expected in the coming weeks.
“Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant,” the company said in a statement.
Pfizer and BioNTech said that if necessary they expect to be able to ship a new vaccine tailored to the emerging variant in approximately 100 days.
I hear the CASH REGISTERS already ringing-up more Billions of Dollars! Cha-Ching!
S.African doctor says Omicron patients have ‘very mild’ symptoms
It may turn out that everyone went into EMERGENCY MODE when this Variant may turn out to be nothing. Might be the CURE against Deadly Strains. ?